Search In this Thesis
   Search In this Thesis  
العنوان
Right ventricular dysfunction as a predictor of no response and clinical outcome following CRT /
الناشر
Mohamed Fawzi Abdu Abdu ,
المؤلف
Mohamed Fawzi Abdu Abdu
هيئة الاعداد
مناقش / Mohamed Fawzi Abdu Abdu
مشرف / Aliaa Abdel fattah
مشرف / Randa Ali Soliman
مشرف / Ayman Gaber
مشرف / Mohammad Afifi
تاريخ النشر
2016
عدد الصفحات
230 P. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
طب الطوارئ
تاريخ الإجازة
16/9/2016
مكان الإجازة
جامعة القاهرة - كلية الطب - Critical Care Medicine
الفهرس
Only 14 pages are availabe for public view

from 264

from 264

Abstract

The aim of our work is to study the effect of impaired RV function on the response and clinical outcome of CRT patients The study included 30 cardiomyopathy patients with refractory heart failure, fulfilling criteria for CRT implantation They were subdivided prospectivly according to their RV function into 2 equal groups (A&B) with 15 patients in each There was no significant difference between the 2 groups in the pre- implantation data as age, sex, risk factors, aetiology of HF, laboratory data. All the patients take full anti-failure medications, according to guideline with maximum tolerable doses The implantation data showed no significant difference between the two groups except the higher number of the CRT leads (3 lead system) in group A Comparison between the 2 groups showed superiority of group A as regard the clinical improvement of the NYHA class, 6MWD and HR regression, but there was no significant differences in QOL score. group B showed higher incidence of hospitalization for HF related complications and for none cardiac hospitalizations. Evaluating Reversed remodeling by Echo showed superiority of group A in the regression of LA dimensions, regression of LV dimensions and volumes, improvement in EF and Tei index. But there was no significant difference between them in the EPSS and D.D. As regard the CRT response there was higher incidence of responders in group A clinically (11 patients, 73.3%) and by echo (13 patients, 86.5%) as compared to group B (10 patients, 66.6%) clinically and by echo (4 patients, 26.6%)